Pharma IQ Glossary: Anti-Interferon
Anti-Interferon is an antibody to an interferon. It is used for the purification of interferons. The untoward effects of the interferons can be reversed or prevented by simultaneously adding anti-interferon (usually an antibody). This helps in treating many diseases, especially viral infections.
The R&D Race behind Immune Checkpoint Modulators
November 14 by Chanice HenryThe cancer immunotherapy market is primed for growth, with Immune Checkpoint Inhibitors, otherwise known as Immune Checkpoint Modulators, representing one of the area’s newest and most promising treat...
New Treatments to Boost Hep C Market to $19.2bn by 2016
July 01 by Pharma IQ NewsThe launch of interferon-free regimens is expected to boost the hepatitis C market from $2.9bn in 2013 to a peak of $19.2bn in 2016, according to independent analysts Datamonitor Healthcare.The superi...
Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive
February 18 by Pharmaceuticals & Biotechnology EditorIn this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterf...
How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?
January 26 by Pharma IQCases of counterfeit pharmaceuticals being discovered entering the United States are on the up.Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures...
How to Successfully Use Anti-Counterfeiting Technologies to Reduce Costs and Increase Your Business Value
June 08 by Pharma IQ"Fraudulent medicines offer organised criminal groups a high return commodity with relatively low risks, ultimately at the expense of the health of unsuspecting people," Yury Fedotov, executive direct...
Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil’s Anti-Counterfeiting Regulatory Requirements
May 24 by Pharma IQ NewsCranbury, New Jersey, May 24, 2011- Systech International, innovator of Packaging Execution Systems (PES), and our Brazilian Partner Videojet today announced that one of the world’s largest pharmaceut...
Don’t Get Lost in Translation – Reflections on Pharmaceutical Labelling
May 07 by Helen WinsorMark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive intervi...
The True Cost of Not Having Brand Protection
February 16 by Pharma IQWith the performance of new and existing IPs potentially being the difference between success and failure in the modern business world, it is arguably more important than ever that these are protected...
The MHRA Review and Clinical Trials in Cancer
January 17 by Helen WinsorJames McBlane, Preclinical Assessor in the Clinical Trials Unit, Medicines & Healthcare products Regulatory Agency (MHRA), joins Pharma IQ to discuss clinical trials in patients with advanced...
Merck Serono and Actavis Join Forces at Pharmaceutical Anti-Counterfeiting to Brainstorm How to Ensure Patient Safety
January 05 by Pharma IQ NewsMark Edwards, Global Freight Manager from Actavis and John Franks, Security Director EMEA from Merck Sharp & Dohme, joined forces in order to explore how patient safety could be improved by p...
61.5% of Pharma Professionals Believe 2010 Worst Year Yet for Counterfeiting
December 14 by Pharma IQ NewsAccording to a new survey published by Pharma IQ on pharmaceutical anti-counterfeiting 61.5 percent respondents found that the threat of counterfeit medicines this year is more severe than ever a...
5 Things You Should Know about Pharmaceutical Anti-Counterfeiting
December 13 by Helen WinsorSébastien Mauel, Head of Product Security at Ares Trading SA, an affiliate of Merck Serono SA, joins Pharma IQ to discuss anti-counterfeiting. Pharma IQ: How severe would you say the counterfeiting s...
